The following data is included in the latest annual publication for MSSA bacteraemia.
Results by NHS organisation and sub-integrated care board location (SICBL)
financial year counts and rates of C. difficile infection and by prior trust exposure from April 2007 to March 2023financial year counts and rates of MRSA bacteraemia and by onset status from April 2007 to March 2021quarterly counts of MSSA bacteraemia by NHS acute trust and by onset status from January 2011 to March 2018 - all reported cases (table 11a)quarterly counts of MSSA bacteraemia by NHS acute trust from January 2011 to March 2018 - trust apportioned cases only (table 11b)financial year counts and rates of MSSA bacteraemia by NHS acute trust from April 2011 to March 2018 - all reported cases (table 12a)financial year counts and rates of MSSA bacteraemia by acute trust from April 2011 to March 2018 - trust apportioned cases only (table 12b)Results by clinical commissioning group (CCG)
quarterly counts of MSSA bacteraemia by clinical commissioning group (CCG) from January 2011 to March 2018 (table 13)financial year counts and rates of MSSA bacteraemia by clinical commissioning group (CCG) from April 2011 to March 2018 (table 14)quarterly counts of MSSA bacteraemia by acute trust from January 2011 to March 2017 - all reported cases (table 11a)quarterly counts of MSSA bacteraemia by acute trust from January 2011 to March 2017 - trust apportioned cases only (table 11b)financial year counts and rates of MSSA bacteraemia by acute trust from April 2011 to March 2017 - all reported cases (table 12a)financial year counts and rates of MSSA bacteraemia by acute trust from April 2011 to March 2017 - trust apportioned cases only (table 12b)quarterly counts of MSSA bacteraemia by clinical commissioning group (CCG) from January 2011 to March 2017 (table 13)financial year counts and rates of MSSA bacteraemia by clinical commissioning group (CCG) from April 2011 to March 2017 (table 14)
This is an extract. The publication continues at the source.